Cargando…
M098 A CASE OF HEREDITARY A-TRYPTASEMIA EXACERBATION FOLLOWING SECOND DOSE OF MRNA COVID-19 VACCINE ON OMALIZUMAB
Autores principales: | Li, J., Saff, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566848/ http://dx.doi.org/10.1016/j.anai.2021.08.252 |
Ejemplares similares
-
Covid-19-vaccine-pfizer-biontech/omalizumab: Exacerbation of hereditary alpha-tryptasemia: case report
Publicado: (2022) -
Lipidomic analysis of urinary exosomes from hereditary α‐tryptasemia patients and healthy volunteers
por: Glover, Sarah C., et al.
Publicado: (2019) -
Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond
por: Sprinzl, Bettina, et al.
Publicado: (2021) -
Hereditary alpha-tryptasemia modifies clinical phenotypes among individuals with congenital hypermobility disorders
por: Vazquez, Maribel, et al.
Publicado: (2022) -
Impact of naturally forming human α/β-tryptase heterotetramers in the pathogenesis of hereditary α-tryptasemia
por: Le, Quang T., et al.
Publicado: (2019)